Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about AZN
Recent news which mentions AZN
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
32
33
Next >
War over drug-cost assistance traps sickest patients in the middle
October 03, 2022
Tickers
ABBV
AZN
PFE
Tags
PFE
ABBV
AZN
From
MarketWatch
Will Chart Analysts Notice Bad Omen on AstraZeneca's Chart
October 03, 2022
Tickers
AZN
Tags
BZI/CROSS
Market News
Movers
From
Benzinga
Why Is LogicBio (LOGC) Stock Up 600% Today?
October 03, 2022
Tickers
AZN
BBBY
LOGC
LVWR
Tags
LVWR
LOGC
NASDAQ:LOGC,NASDAQ:AZN,NASDAQ:BBBY,NYSE:LVWR
From
InvestorPlace
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
October 03, 2022
Tickers
AZN
JNJ
KTTA
MRNA
Tags
Partner Content
MRNA
AZN
From
Benzinga
Why LogicBio Therapeutics Stock Is Soaring Today
October 03, 2022
Tickers
AZN
LOGC
Tags
Benzinga
Penny Stocks
Trading Ideas
From
Benzinga
Why Are LogicBio Therapeutics Shares Skyrocketing Today?
October 03, 2022
Tickers
AZN
AZNCF
LOGC
Tags
AZN
Large Cap
Biotech
From
Benzinga
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
October 02, 2022
Tickers
ALNY
AMLX
AZN
BLUE
Tags
AZN
Benzinga
Penny Stocks
From
Benzinga
What This News Means for Merck
October 01, 2022
Tickers
AZN
MRK
RHHBY
Tags
Market News
MRK
AZN
From
Motley Fool
PhaseBio Might Have To Return Global Rights To Its Lead Program
September 28, 2022
Tickers
AZN
PHAS
Tags
General
News
Briefs
From
Benzinga
7 Large-Cap Stocks With Sustained Dividend Growth Potential
September 28, 2022
Tickers
AAPL
AZN
COST
CVX
Tags
Market News
T
COST
From
InvestorPlace
Japan Approves AstraZeneca's Two Treatments For Asthma, Rare Form Of Cancer
September 27, 2022
Tickers
AZN
AZNCF
Tags
Benzinga
AZNCF
Market News
From
Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
September 27, 2022
Tickers
ABT
AZN
BNTX
CODX
Tags
Market News
VALN
PFE
From
InvestorPlace
US Stock Futures Rise Ahead Of Economic Reports, Fed Speakers; Crude Oil Rises 1%
September 27, 2022
Tickers
AZN
DPZ
JBL
JG
Tags
News
Pre/Market Outlook
JG
From
Benzinga
Adding $100 to These 7 Stocks Would Be a Genius Move Right Now
September 27, 2022
Tickers
AZN
DIS
EPD
FVRR
Tags
FVRR
EPD
Market News
From
Motley Fool
Burberry Finance Chief Joins GSK As First Woman CFO
September 26, 2022
Tickers
AZN
BBRYF
BURBY
GSK
Tags
Biotech
Large Cap
AZN
From
Benzinga
European Stocks Are Left In Shambles From Russia-Ukraine War: It May Be Time To Buy These 2 High Yielders
September 25, 2022
Tickers
AZN
PHG
SPEU
Tags
Retail Sales
News
Eurozone
From
Benzinga
Should Growth Investors Buy This Little-Known Stock?
September 24, 2022
Tickers
AZN
VCYT
Tags
AZN
Market News
Recent Press Releases
From
Motley Fool
AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med
September 23, 2022
Tickers
AZN
AZNCF
IONS
Tags
why it's moving
News
Briefs
From
Benzinga
With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma
September 21, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
Biotech
AZN
Health Care
From
Benzinga
AstraZeneca's Asthma Treatment Scores European Approval
September 21, 2022
Tickers
AZN
AZNCF
Tags
European Medicines Agency
Health Care
Biotech
From
Benzinga
Got $5,000? These 2 Growth Stocks Are Near Their 52-Week Lows
September 21, 2022
Tickers
ADBE
AZN
Tags
Market News
ADBE
AZN
From
Motley Fool
AstraZeneca's COVID-19 Antibody Treatment Scores Approval In Europe
September 20, 2022
Tickers
AZN
AZNCF
Tags
Large Cap
Biotech
AZN
From
Benzinga
Europe may give COVID vaccines full marketing authorization to avoid annual review, and WHO backs Gilead’s Veklury for severe disease
September 16, 2022
Tickers
AZN
GILD
MRNA
NVAX
Tags
MRNA
UK:AZN
AZN
From
MarketWatch
AstraZeneca's COVID-19 Antibody Cocktail, RSV Treatment For Infants Gets European Authority Backing
September 16, 2022
Tickers
AZN
AZNCF
SNY
Tags
COVID/19 Coronavirus
General
SNY
From
Benzinga
AstraZeneca's Blood Clot Treatment Hits Primary Goal In Rare Blood Disorder Trial
September 16, 2022
Tickers
AZN
AZNCF
Tags
Market News
AZNCF
Benzinga
From
Benzinga
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
September 14, 2022
Tickers
ABBV
AZN
BMY
LLY
Tags
BMY
ABBV
UK:AZN
From
MarketWatch
Top Financial Stories Tuesday, September 13: Elon Musk's Takeover Set To Get Twitter Shareholder Approval, Intel Slashes Mobileye IPO Valuation, Goldman Sachs To Layoff About 500 Jobs And More...
September 13, 2022
Tickers
AAPL
AMZN
AZN
AZNCF
Tags
AMZN
GOOG
General
From
Benzinga
US Judge Dismisses Shareholder Lawsuit Over AstraZeneca's COVID-19 Vaccine Disclosures: Report
September 13, 2022
Tickers
AZN
AZNCF
Tags
Benzinga
AZNCF
Market News
From
Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
Tickers
ADAP
ALLK
ARQT
AZN
Tags
ALLK
General
ADAP
From
Benzinga
AstraZeneca-Merck's Lynparza Treatment Shows Long-Term Survival In Ovarian Cancer
September 09, 2022
Tickers
AZN
AZNCF
MRK
Tags
Benzinga
MRK
Market News
From
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.